ASX - By Stock
|
KZA |
Re:
KZA Chart
|
|
xlr82nulevels
|
559 |
156K |
5 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
559
|
156K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Appendix 4C - quarterly
|
|
xlr82nulevels
|
32 |
6.8K |
3 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
32
|
6.8K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
622K |
5 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
2.0K
|
622K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
622K |
6 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
2.0K
|
622K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
622K |
13 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
2.0K
|
622K
|
13
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Ceasing to be a substantial holder
|
|
xlr82nulevels
|
67 |
14K |
5 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
67
|
14K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Kazia SP correlation to disallowed watchers
|
|
xlr82nulevels
|
2 |
941 |
4 |
20/07/20 |
20/07/20 |
ASX - By Stock
|
2
|
941
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
9 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
270
|
75K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
622K |
8 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
2.0K
|
622K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
9 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
270
|
75K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
xlr82nulevels
|
2.0K |
622K |
9 |
15/07/20 |
15/07/20 |
ASX - By Stock
|
2.0K
|
622K
|
9
|
|
ASX - By Stock
|
KZA |
Across the pond...Nasdaq: KZIA
|
|
xlr82nulevels
|
270 |
75K |
11 |
14/07/20 |
14/07/20 |
ASX - By Stock
|
270
|
75K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
Alliance A071701: Genomically guided treatment trial in brain metastases.
|
|
xlr82nulevels
|
40 |
12K |
13 |
13/07/20 |
13/07/20 |
ASX - By Stock
|
40
|
12K
|
13
|
|